The North America Toxicology Laboratories market is expected to reach US$ 198.2 Mn by the end of 2022 at a CAGR of 11.1% during the forecast period. On the basis of drug class, the North America toxicology laboratories market is segmented into alcohol, amphetamines, barbiturates, benzodiazepines, opiates/opioids, tricyclic antidepressants, and Z-Drugs. Weak regulatory control on prescription drugs with regard to over-the-counter purchases has been resulting in increased substance abuse and for amphetamines in particular. This increased consumption is fueling the demand for drug toxicology testing of amphetamines across the U.S. Amphetamines drug toxicity testing segment has been estimated to contribute highest in terms of revenue, accounting for 27.7% of the total toxicology laboratories market share in 2015. The opiate/opioids drug class segment has been estimated to be the fastest-growing segment of the North America toxicology laboratories market, registering a CAGR of 13.3% during the forecast period.
By drug class, the North America toxicology laboratories market is segmented into, alcohol, amphetamines, barbiturates, benzodiazepines, opiates/opioids, tricyclic antidepressants, and Z-Drugs. Amphetamine, opiate/opioids, benzodiazepines, and barbiturates segments have been estimated to emerge as the highest revenue generating segments, collectively accounting for around 81% share of the overall market value in 2015.
By product type, the market is broadly segmented into instrument and reagents and kits. Instrument segment is further sub-segmented into immunochemistry analyzers, PCR machine, gas chromatography (GC)-mass spectrometry (MS), and high-performance liquid chromatography (HPLC). Reagents and kits segment is further sub-segmented into, ELISA kits, PCR kits, enzyme multiplied immunoassay technique (EMIT), and radio immuno-sorbent assay (RIA).
Download Report Sample @ http://www.persistencemarketresearch.com/samples/9707
By sample type, urine sample segment is expected to contribute highest in terms of revenue over the forecast period. This is due to its non-invasive nature and ease of collection method, which promotes its application in analyzing alcohol, opioids, and amphetamine drugs.
By end user, the forensic laboratories segment is expected to be the highest revenue generating segment, owing to wide usage of drug testing across federal agencies and various production industries. Forensic laboratories segment has been estimated to account for around 48% share of the overall North America toxicology laboratories market in 2015.
By country, the U.S. dominated has been estimated to remain the dominant market, with over 83% market share in 2015, owing to controlled substance abuse and active regulatory guidelines to curtail the abusive consumption of controlled drugs.
Key players operating in the North America toxicology laboratories market include Thermo Fisher Scientific, Agilent Technologies, Bio Rad Laboratories Inc., Alere Inc., Eurofins Scientific, Neogen Corporation, Enzo Life Sciences, Inc., and Vala Sciences Inc.
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Persistence Market Research
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353